Long-term kidney and pancreas function with tacrolimus immunosuppression following simultaneous kidney and pancreas transplantation. 1998

V R Peddi, and R Munda, and A M Demmy, and J W Alexander, and M R First
Department of Internal Medicine, University of Cincinnati Medical Center, Ohio, USA.

UI MeSH Term Description Entries
D007166 Immunosuppressive Agents Agents that suppress immune function by one of several mechanisms of action. Classical cytotoxic immunosuppressants act by inhibiting DNA synthesis. Others may act through activation of T-CELLS or by inhibiting the activation of HELPER CELLS. While immunosuppression has been brought about in the past primarily to prevent rejection of transplanted organs, new applications involving mediation of the effects of INTERLEUKINS and other CYTOKINES are emerging. Immunosuppressant,Immunosuppressive Agent,Immunosuppressants,Agent, Immunosuppressive,Agents, Immunosuppressive
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D002096 C-Peptide The middle segment of proinsulin that is between the N-terminal B-chain and the C-terminal A-chain. It is a pancreatic peptide of about 31 residues, depending on the species. Upon proteolytic cleavage of proinsulin, equimolar INSULIN and C-peptide are released. C-peptide immunoassay has been used to assess pancreatic beta cell function in diabetic patients with circulating insulin antibodies or exogenous insulin. Half-life of C-peptide is 30 min, almost 8 times that of insulin. Proinsulin C-Peptide,C-Peptide, Proinsulin,Connecting Peptide,C Peptide,C Peptide, Proinsulin,Proinsulin C Peptide
D003404 Creatinine Creatinine Sulfate Salt,Krebiozen,Salt, Creatinine Sulfate,Sulfate Salt, Creatinine
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D005951 Glucose Tolerance Test A test to determine the ability of an individual to maintain HOMEOSTASIS of BLOOD GLUCOSE. It includes measuring blood glucose levels in a fasting state, and at prescribed intervals before and after oral glucose intake (75 or 100 g) or intravenous infusion (0.5 g/kg). Intravenous Glucose Tolerance,Intravenous Glucose Tolerance Test,OGTT,Oral Glucose Tolerance,Oral Glucose Tolerance Test,Glucose Tolerance Tests,Glucose Tolerance, Oral
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft

Related Publications

V R Peddi, and R Munda, and A M Demmy, and J W Alexander, and M R First
January 2003, Clinical transplantation,
V R Peddi, and R Munda, and A M Demmy, and J W Alexander, and M R First
April 1995, Transplantation,
V R Peddi, and R Munda, and A M Demmy, and J W Alexander, and M R First
December 2000, Transplantation proceedings,
V R Peddi, and R Munda, and A M Demmy, and J W Alexander, and M R First
January 2001, Transplantation proceedings,
V R Peddi, and R Munda, and A M Demmy, and J W Alexander, and M R First
March 1998, Transplantation proceedings,
V R Peddi, and R Munda, and A M Demmy, and J W Alexander, and M R First
February 2003, Clinical transplantation,
V R Peddi, and R Munda, and A M Demmy, and J W Alexander, and M R First
March 2016, Journal of bone and mineral metabolism,
V R Peddi, and R Munda, and A M Demmy, and J W Alexander, and M R First
January 1997, Transplant international : official journal of the European Society for Organ Transplantation,
V R Peddi, and R Munda, and A M Demmy, and J W Alexander, and M R First
April 2004, Transplantation proceedings,
Copied contents to your clipboard!